Howard & Jan Oringer Seminar
Computational Biology in Translational Cancer Research
Computational biology is playing important roles in precision cancer therapy. I will discuss our efforts using computational biology to mine high throughput sequencing data in order to aid translational cancer research. Specifically I will discuss three areas of our current foci: using public ChIP-seq data to understand cancer gene regulation, using CRISPR screen data to identify tumor vulnerabilities and targeted combination therapy, and using RNA-seq data to model tumor infiltrating Xiaole Shirleyimmune cells and T-cell repertoires.
Contact: Diane Goodfellow at 626-395-6842 email@example.com